Solid tumours and malignant haemopathies – Eurofins Biomnis
We offer a complete range of analytical tests allowing the diagnostic, prognostic and theranostic evaluation of all malignant haemopathies (chronic lymphoproliferative syndromes, myelomas, chronic myeloproliferative neoplasias, myelodysplastic syndromes, acute leukaemias, etc.) and a wide spectrum of solid tumours (breast, lung, colorectal & gastric cancers, melanomas, sarcomas, etc.). The various departments employ state-of-the-art technology (10-colour flow cytometers, automatic metaphase finders, sequencing platforms…) operated by technicians specialised in clinical pathology. Our physicians, pharmacists and clinical pathologists are members of the following societies: GFHC (French Cellular Haematology Group), SFH (French Haematology Society), AFC (French Cytometry Association), GFCH (Francophone Group for Cytogenetic Haematology), ACLF (Francophone Cytogeneticists Association), GFCO (French Group for Study of Cytogenetics in Oncology) and GBMHM (Molecular Biology Group for Haematological Malignancies). The Cellular Haematology/Cytogenetics Department is fully accredited for all the analyses it performs, in accordance with the NF EN ISO 15189 standard.

More information

Document
B8-INTGB – Malignant Blood Disorders request form.
Document
B9-INTGB – Oncology-Solid tumors request form.
Parole d'Expert
Biological management of of hematological malignancies
Everything you need to know about biological management of hematological malignancies explained in a few minutes by Dr Benoît QUILICHINI, clinical pathologist at the Eurofins Biomnis laboratory.
L'affichage de la vidéo est désactivé. Veuillez accepter les cookies
Focus on
Pathological diagnosis and follow up of patients with Acute Leukemia (DS3-INTGB)
Focus on
Pathological diagnosis and follow up of patients with Chronic Myeloid Neoplasms (DS2-INTGB)
Focus on
Pathological diagnosis and follow up of patients with Mature Lymphoïd Neoplasms (DS62-INTGB)
Publication
Automation of ALK gene rearrangement testing with fluorescence in situ hybridization (FISH): A feasibility study
Zwaenepoel k, Merkle D, Cabillic F, Berg E, Belaud-Rotureau MA, Grazioli V, Herelle O, Hummel M, Le Calve M, Lenze D, Mende S, Pauwels P, Quilichini B, Repetti E Exp Mol Pathol 2015 ; 98:113-118
Publication
Characterization of Plasma Cell-Free DNA Integrity Using Droplet-Based Digital PCR: Toward the Development of Circulating Tumor DNA-Dedicated Assays
Geoffroy Poulet, Fanny Garlan, Sonia Garrigou, Eleonora Zonta, Leonor Benhaim, Marie-Jennifer Carrillon, Audrey Didelot, Delphine Le Corre, Claire Mulot, Philippe Nizard, Frederic Ginot, Audrey Boutonnet-Rodat, Helene Blons, Jean-Baptiste Bachet, Julien Taïeb, Aziz Zaanan, Vanna Geromel, Laurence Pellegrina, Pierre Laurent-Puig, Shu-Fang Wang-Renault and Valerie Taly Frontiers in Oncology 06/05/2021
Publication
Cytogenetics in the management of multiple myeloma: an update by the Groupe francophone de cytogénétique hématologique (GFCH)
Daudignon A, Quilichini B, Ameye G, Poirel H, Bastard C, Terré C Ann Biol Clin 2016 ; 74:588-595
Publication
Genetic Characterization of B-Cell Prolymphocytic Leukemia (B-PLL): A Hierarchical Prognostic Model Involving MYC and TP53 Abnormalities
On Behalf of the Groupe Francophone De Cytogenetique Hematologique (GFCH) and the French Innovative Leukemia Organization (FILO) Group Elise Chapiro, Elodie Pramil, M’boyba Diop, Damien Roos-Weil, Clémentine Dillard, Clémentine Gabillaud, Karim Maloum, Catherine Settegrana, Lucile Baseggio, Jean-François Lesesve, Mélanie Yon, Ludovic Jondreville, Claude Lesty, Frédéric Davi, Magali Le Garff-Tavernier, Nathalie Droin, Philippe Dessen, Caroline Algrin, Véronique Leblond, Jean Gabarre, Simon Bouzy, Virginie Eclache, Baptiste Gaillard, Evelyne Callet-Bauchu, Marc Muller, Christine Lefebvre, Nathalie Nadal, Antoine Ittel, Stéphanie Struski, Marie-Agnès Collonge-Rame, Benoit Quilichini, Sandra Fert-Ferrer, Nathalie Auger, Isabelle Radford-Weiss, Lena Wagner, Sebastian Scheinost, Thorsten Zenz, Santos A. Susin, Olivier A. Bernard, Florence Nguyen-Khac Blood 2018 132:943; doi:
Publication
Interférences sérologiques du traitement du myélome multiple par daratumumab (anti-CD38) : à propos d’un cas
Rabut E, Castro-Fernandez A, Le Gall V, Meknache Ann Biol Clin 2017 ; 75:351-355
Publication
Isolated isochromosomes i(X)(p10) and idic(X)(q13) are associated with myeloid malignancies and dysplastic features
Penther D, Etancelin P, Lusina D, Bidet A, Quilichini B, Gaillard B, Rafdord-Weiss I, Mozziconacci MJ, Ittel A, Roche-Lestienne C, Barin C, Soler G, Daudignon A, Nadal N, Chapiro E, Lefebvre C, Godon C, Nadeau G, Mugneret F, Richebourg S, Viailly PJ, Ferret Y, Nguyen-Khac F, Eclache V; Groupe Francophone de Cytogénétique Hématologique Am J Hematol 2019 Aug 4. doi: 10.1002/ajh.25601.
Publication
Les niveaux de preuve des biomarqueurs utilisés pour la détection précoce des cancers de la prostate
Lamy PJ, Gauchez AS, Salomon L et al et le Groupe de biologie de la prostate : Sault C et al Ann Biol Clin 2016 ; 74:227-232

Mettez à jour votre navigateur pour consulter ce site

Mettez à jour votre navigateur pour consulter ce site